Alleviating pain with controlled breathing has been practiced throughout human history. Despite its wide use and long history, a neural circuit-based understanding of the pain-breathing interaction is largely lacking.
Introduction
Breathing is a fundamental, life-sustaining function for animals 1 . Its rhythmicity is automatically generated and maintained homeostatically by rhythm-generating properties of a neuronal network in the medulla to sustain blood oxygen levels in response to changing oxygen needs 2 . However, breathing rhythms are also regulated by interoceptive and exteroceptive signals, such as emotional and sensory stimuli 3 . Pain is an emotional and sensory stimulus that greatly influences breathing behaviors. Intense and uncontrollable pain induces hyperventilation in humans 4 . Conversely, controlled breathing has been widely used as a nonpharmacological intervention for treating pain 5, 6 , as well as affective disorders [5] [6] [7] [8] . Although this reciprocal interaction between pain and breathing behaviors has been reported in a number of clinical and laboratory studies in human subjects 4 , investigations on molecular and circuit-based understanding of pain-breathing interactions is essentially lacking.
There are three respiration centers in the brain: the ventral respiratory group (VRG), the dorsal respiratory group (DRG), and the pontine respiratory group (PRG) 2 . The VRG and DRG are located in the medulla and act as generators of breathing rhythm and pattern 2, 9, 10 . However, the PRG, located in the pons, is not involved in generating respiratory rhythm, but has been proposed to have modulatory roles in response to interoceptive and exteroceptive signals 11 . This hypothesis is largely based on its anatomical location, which connects the forebrain and limbic structures to the medullary respiratory centers. However, supporting evidence for this hypothesis is limited. Although there are a few pioneering studies that have investigated 3 non-homeostatic breathing behaviors 12, 13 , the majority of research has focused on homeostatic regulation of respiratory networks. Therefore, to extend our knowledge for these respiratory behaviors, we should broaden the scope of research to interoceptive or exteroceptive regulation of breathing rhythm. Exploring the reciprocal interaction between pain and breathing will not only extend our knowledge of basic research on breathing behaviors, it will also broaden our understanding of breathing as a behavioral intervention of pain and anxiety. Here, we report that PBL Oprm1 neurons in the PRG play a key role in non-homeostatic breathing regulation and the pain-breathing interactions.
Results

Correlation of PBL Oprm1 activity and breathing rate
Whole-body plethysmography (WBP) is the most widely used tool for monitoring breathing behaviors 14 , because it provides multiple parameters for breathing behaviors with high precision. However, due to its closed configuration, it is difficult to access the brain during respiratory measurement. Moreover, its small chamber size hinders behavioral assessments for monitoring emotional behaviors in mice. To overcome this issue, we monitored breathing behaviors by measuring temperature fluctuation in the nasal cavity during gas exchange with a micro-thermistor implanted into the nasal cavities of test mice 15 . This approach may not provide as many breathing parameters as the WBP, but it renders unprecedented freedom to access the brain while simultaneously monitoring breathing behaviors. It also is possible to monitor breathing behaviors in unrestrained mice during behavioral tests. With this configuration, in combination with fiber photometry calcium imaging in vivo, we monitored activity of the PBL Oprm1 neurons and breathing behaviors in mice expressing a genetically encoded calcium indicator, jGCaMP7s, in their home cage (Fig.   1A, B) . To express jGCaMP7s specifically in the PBL Oprm1 neurons, a recombinant adeno-associated virus that expresses jGCaMP7s (AAV-DIO-GCaMP7s) in a Cre-dependent manner was stereotaxically injected into the PBL of a Cre-driver mouse line that expresses the Cre recombinase in the Oprm1-expressing neurons (Oprm1 Cre/+ mice) three weeks prior to the tests. Simultaneous measurements of neural activity and breathing behaviors showed a close correlation (Fig. 1C, D, Fig. S1A-C) . Aligning the calcium traces with the onset of the breathing-rate increases show that single calcium events and breathing-rate increases are tightly correlated (Fig. 1E) . Convergent cross-mapping (CCM) analysis, a nonlinear time series embedding algorithm that tests the causality of two independent time-series data 16 , can generate a model that predict the change in respiratory rate from calcium traces with greater than 95 % accuracy (Fig. 1F, G) . These results suggest that PBL Oprm1 neurons are involved in gross changes of breathing rates.
PBL
Oprm1 neurons regulate breathing rhythm
To test if changes in breathing rates are mediated by the PBL Oprm1 neurons, we manipulated these neurons selectively using both chemogenetic (with awake mice) and optogenetic approaches (with anesthetized mice). Oprm1 Cre/+ mice were stereotaxically injected with either AAV-DIO-hM3Dq-mCherry (Fig. S2A) or AAV-DIO-hM4Di-mCherry (Fig. S2E) into the PBL to selectively activate or inhibit PBL Oprm1 neurons by injecting 5 mg/kg Clozapine-N-Oxide (CNO, 5 mg/kg), respectively. AAV-DIO-eYFP was injected as a control. Three weeks after injection, breathing rates were monitored with WBP in awake mice 30 minutes after CNO injection. Selective activation of PBL Oprm1 neurons in the hM3Dq-expressing group displayed significant increases in breathing rates as compared to the saline injected group, whereas no increase was observed in control eYFP-expressing mice (Fig. S2B, C) . The action of CNO in this group was confirmed with ex vivo slice electrophysiological recordings with cell-attached configuration. Bath application of 3 µM CNO dramatically increased the firing rate of the PBL Oprm1 neurons in the hM3Dq-expressing
Oprm1
Cre/+ mice (Fig. S2D) . Selective inactivation in the hM4Di-expressing group by CNO displayed a significant decrease in breathing rate compared to the saline injected group, whereas no decrease was observed in the control eYFP group. (Fig. S2F, G) . Bath application of 3 µM CNO in the slice of the same group of mice showed complete silencing of action potential firing in whole-cell patch clamp configuration (Fig. S2H) . These data indicate that PBL Oprm1 neurons are necessary and sufficient for modulating breathing rates in awake, behaving mice. We wondered whether these neurons can also regulate breathing rates in lightly anesthetized mice. We used optogenetics to test this idea. We first injected AAV-DIO-ChR2-eYFP into the PBL of the Oprm1 Cre/+ mice to selectively activate these neurons ( Fig. 2A) . We then monitored breathing rates in anesthetized mice with inductance plethysmography by placing piezo-based pressure sensors beneath the chests of test mice to detect chest expansion during breathing 17 . Optogenetic stimulation of these neurons significantly increased the breathing rates of the anesthetized mice (Fig. 2B, C ).
Optogenetic inhibition with ArchT ( Fig. 2D ) resulted in a significant suppression of breathing rates compared to the eYFP-expressing control group (Fig. 2E, F) . Note that the basal breathing rate under anesthesia is much lower than in awake mice. These data suggest that PBL Oprm1 neurons control breathing behaviors, regardless of the conscious state of the test mice.
Input/output pathways of PBL Oprm1 neurons
We investigated the brain regions that are connected with PBL Oprm1 neurons. To identify direct upstream neurons, we performed monosynaptic, retrograde tracing with G-deleted pseudotyped rabies virus (RVdG) (Fig. 3A ) 18 . Recombinant AAV expressing avian sarcoma leucosis virus glycoprotein EnvA and rabies glycoprotein (AAV8-hSyn-FLEX-TVA-P2A-GFP-2A-oG) in a Cre-dependent manner were injected into the PBL of the Oprm1 Cre/+ mice. Three weeks after the injection, RVdG encoding mCherry (RVdG-mCherry) 5 was injected into the same area. These mice were euthanized and perfused seven days after the RVdG injection to identify brain areas that express mCherry. The results showed that there are multiple brain areas that are directed connected to PBL Oprm1 neurons (Fig. 3B) , including limbic areas such as central nucleus of the amygdala (CeA), the bed nucleus of the stria terminalis (BNST), the parvocellular subparafascicular nucleus (SPFp), the parasubthalamic nucleus (PSTN), as well as midbrain/brainstem areas such as the nucleus tractus solitarius (NTS), the superior colliculus (SC) (Fig. 3A) . Interestingly, these areas are known to either relay aversive sensory signals or integrate sensory information with emotional valence [19] [20] [21] [22] . We also investigated downstream brain areas that receive direct input from the PBL Oprm1 neurons by stereotaxic injection of recombinant AAV that express ChR2:eYFP in a Cre-dependent manner (AAV-DIOChR2:eYFP), which is expressed in the cell body and axon terminals (Fig. S3) . YFP fluorescence was observed in the CeA, BNST, SPFp, PSTN, and preBötC. Interestingly, most of these regions are reciprocally connected to and from the PBL Oprm1 neurons. Among these areas, preBötC is well-known as a central rhythm generator of breathing rhythm 23 . To confirm the axonal projections of these neurons to the preBötC, we stereotaxically injected recombinant AAV expressing nuclear tdTomato in a Cre-dependent manner and synaptophysin-eGFP fusion protein (AAV-DIO-tdT-Syn:eGFP), which is targeted to the axon terminals (Fig. 3C) . We confirmed that the eGFP signals from axonal terminals of PBL Oprm1 neurons are colocalized with the somatostatin (SST)-positive signals, which are markers of preBötC neurons (Fig. 3D) .
We reasoned that the PBL Oprm1 neurons may regulate breathing rates by modulating the activity of rhythm generating neurons located in the preBötC. To test this hypothesis, we expressed hM3Dq into the PBL
Oprm1
neurons by stereotaxically injecting AAV-DIO-hM3Dq-mCherry into the PBL of the Oprm1 Cre/+ mice.
Three weeks after injection, the axon terminals of PBL Oprm1 neurons in the preBötC area were activated by stereotaxic injection of 200 nl of clozapine (1 µg/ml) 24 into the preBötC area (Fig. 3F) . We included controls to ensure that clozapine selectively actives DREADD-expressing neurons. Selective stimulation of preBötC-projecting terminals from the PBL Oprm1 neurons resulted in a significant increase in breathing rates in anesthetized Oprm1 Cre/+ mice (Fig. 3E, G) . Collectively, these results suggest that the PBL
neurons can regulate breathing behaviors by conveying signals from the limbic and midbrain / brainstem areas to preBötC rhythm generating neurons.
Pain increases breathing rates via PBL
Oprm1 neurons PBL Oprm1 neurons receive monosynaptic inputs from the brain areas that mediates pain perception and emotional regulation. Therefore, we tested if they are responsible for the reciprocal interaction of pain and breathing. We monitored breathing behavior and PBL Oprm1 activity in response to noxious sensory stimuli in anesthetized mice. Breathing rates were monitored with inductance plethysmography using a piezo sensor under the chests of anesthetized mice and calcium signals were monitored with fiber photometry (Fig. 4A, F) . We stimulated the mice with thermal pain by touching a temperature-controlled rod (55 o C) 6 to the tail of anesthetized mice (Fig. 4A) . Thermal pain robustly increased both the breathing rates ( Fig.   4B , C) and calcium signals (Fig. 4D, E) . The same group of mice were also tested with mechanically noxious stimuli (Tail pinch with 300 g pressure) (Fig. 4F) , which also robustly increased both breathing rates ( Fig. 4G, H ) and calcium signals (Fig. 4I, J) . We also tested this hypothesis in freely moving mice using thermistor-based plethysmography in combination with fiber photometry in thermistor-implanted
Oprm1
Cre/+ mice that express jGCaMP7s in the PBL Oprm1 neurons (Fig. S4A) . The test mice were placed on the surface of the hot plate and habituated at room temperature. Increasing the surface temperature from room temperature to 55°C induced dramatic increases in both breathing rates and calcium signals in awake mice ( Fig. S4B-D) . Cross-correlation analysis showed that these activities were tightly correlated (Fig.   S4E ). We then inhibited these neurons through optogenetic silencing to test whether these neurons are responsible for the increase in breathing rates by pain signals. The anesthetized Oprm1 Cre/+ mice expressing
ArchT in the PBL Oprm1 neurons were placed on the piezo sensor, and the PBL Oprm1 neurons were optogenetically silenced during the thermal-and mechanical-pain induction (Fig. 4K) . Optogenetic inhibition of these neurons significantly decreased both the thermal (Fig. 4L) and mechanical ( Fig. 4M) pain-induced increases in breathing rates. In contrast, it failed to decrease pain-induced breathing rate increase in the eYFP control group. These results show that the PBL Oprm1 neurons can mediate the increase in pain-induced breathing rate.
Inhibiting PBL Oprm1 activity alleviates pain
Human studies have shown that slow breathing alleviates pain 5 . To test if decreases in breathing rates attenuate pain perception, we chemogenetically inhibited PBL Oprm1 neurons and performed somatosensory perception tests. To test thermal sensitivity, Oprm1 Cre/+ mice expressing hM4Di in the PBL Oprm1 neurons were injected with CNO (7.5mg/kg) 45-60 min prior to the hot-plate test. Latency of paw withdrawal or licking on the hot plate was monitored. Latency was not significantly different compared to neurons expressing eYFP (Fig. S5A, B) . Likewise, mechanical sensitivity with the same group of mice in automatic von Frey test showed no difference compared to eYFP-control mice ( . Therefore, these results suggest that inactivating PBL Oprm1 neurons attenuates the affective-motivational aspect of pain without altering the 7 sensory perception of pain. To further test this idea, we performed a fear-conditioning test (Fig. 5D) . In classical Pavlovian, fear conditioning, foot-shock pain is a motivational signal to remember noxious cues or contexts. Therefore, freezing behavior after conditioning is directly correlated with perception of the affective-motivational aspect of pain. During the training session of contextual fear conditioning, the freezing behaviors of the control group of mice gradually increased as the 0.2-mA foot shock was repeatedly delivered, but the hM4Di-expressing mice displayed significant attenuation of freezing in response to the same stimuli (Fig. 5E) . The attenuated freezing response of the hM4Di group persisted during the fearmemory test 24 hr after the training compared to eYFP control mice (Fig. 5F ). An elevated-plus-maze (EPM) test showed that mice with chemogenetic inactivation of the PBL Oprm1 neurons spent significantly longer time ( Fig. 5G-I ) and visited open arms more frequently (Fig. S5E, F ) compared with the control group. We also performed real-time place preference (RTPP) ( ArchT-expressing mice stayed significantly longer time in the "light-on" chamber as compared with the "light-off chamber", indicating that inactivating the PBL Oprm1 neurons is preferred, whereas the control mice expressing eYFP spent equal time in both chambers ( Fig. 5K, L) . In contrary, the ChR2-expressing mice displayed avoidance behavior towards the "light-on" chamber ( Fig. 5N, O) . Overall, these results indicate that PBL Oprm1 inactivation alleviates the perception of the affective-motivational aspect of pain, leaving the perception of sensory-discriminative pain unaltered by encoding positive valence in mice.
Discussion
We identified a genetically defined circuit that directly regulates breathing rhythm by conveying signals from the limbic / brainstem brain areas to the medullary rhythm generating neurons. Activity of PBL
Oprm1
neurons are tightly correlated with breathing-rate changes in awake, behaving mice, and manipulating the activity of these neurons directly regulates breathing rates in both awake and anesthetized mice. There is a direct connection from PBL Oprm1 neurons to the preBötC that is responsible for breathing regulation.
Furthermore, we show that pain signals increase breathing rates through this ponto-medullary circuit.
Suppressing the activity of this circuit alleviates the affective-motivational aspect of pain, as well as anxiety-like behaviors. Therefore, these findings suggest that inhibiting the PBL Oprm1 to preBötC pathway may be one of the mechanisms by which controlled breathing suppresses pain.
Notably, pain-induced increases in breathing rate occurred in anesthetized mice, and this increase was blocked by inhibiting the PBL Oprm1 neurons. These results suggest that the pain-to-breathing modulation is an autonomic response. Conversely, it is unclear whether breathing-to-pain modulation is an autonomic or 8 non-autonomic response. Decreased chest movement itself may involuntarily generate a sensory feedback that modulates the cognitive perception of pain. Alternatively, the brain's voluntary command to decrease breathing rates directly regulates the activity of PBL Oprm1 neurons, thereby simultaneously generating physiological and emotional outputs. To address this question, it will be necessary to develop a behavioral or physiological paradigm that changes breathing rhythms involuntarily, like the Iron-lung for polio patients.
The identification of the neural circuit that simultaneously regulates both the emotional response of pain and breathing behaviors not only provides a circuit-based understanding of reciprocal breathing and pain modulation, but it also suggests that emotion and physiology may be simultaneously regulated through a common upstream circuit 27,28 . 
Materials and methods
Animals
All protocols for animal experiments were approved by the IACUC of the Salk Institute for Biological Studies according to NIH guidelines for animal experimentation. The Oprm1-Cre:GFP transgenic mouse line used in this study was generated from the lab of Dr. Richard Palmiter 1 . Both male and female mice were used in all studies. Animals were randomized to experimental groups and no sex differences were noted. Mice were maintained on a 12 h light/dark cycle and provided with food and water ad libitum.
Respiratory measurements
Inductance plethysmography
Inductance plethysmography (Fig 1k-l The PowerLab system with LabChart 8 software (ADInstruments Inc., USA) was used for data acquisition, inspiratory and expiratory peak detection and rate and amplitude calculation. Data were sampled at 400 Hz, low-pass filtered at 10 Hz, and smoothed with a 100-ms moving window. Automatic peak detection was validated with manual peak detection.
Whole body plethysmography (WBP)
A custom-built WBP chamber was utilized for measuring respiratory changes (Fig 1i, n) . The PowerLab system with LabChart 8 software was used for data acquisition, inspiratory and expiratory peak detection and rate and amplitude calculation. Data were sampled at 1-kHz, band-pass filtered at 1-10 Hz, and smoothed with a 100-ms moving window. Automatic peak detection was validated with manual peak detection.
Mice were introduced into the WBP chamber for three 20 min habituation sessions before testing. Mice were kept in the chamber for 10-12 min during the testing session before and after the drug injection. After 5-10 min of chamber introduction, a stable pattern was reached and the averaged value of a stabilized 1-min segment was analyzed.
Micro thermistor-based plethysmography
A custom-built micro thermistor (Fig 1b-g, Fig 3k-o) 
Stereotaxic surgery
Mice were anesthetized with isoflurane (5% induction, 1.5-2% maintenance with a nose cone; Dräger Vapor 2000, Draegar, Inc., USA) and placed onto a water recirculating heating pad throughout the surgery. Mice were placed on a stereotaxic frame (David Kopf Instruments, USA), the skull was exposed, and the cranium was drilled with a micro motor handpiece drill (Foredom, USA: one or two holes for viral injection, two holes for screws with implantation, one or two holes for optic fibers, and one hole for a micro thermistor).
The virus was injected unilaterally (right side) or bilaterally into the PBL (anteroposterior (AP), -1 mm from lambda; mediolateral (ML), ±1.5 mm; dorsoventral (DV), -3.5 mm, re-zero at the midline with the same AP). The viral injection was administered with a glass pipette (tips broken for an inner diameter of 20 µm) connected to the Nanoject III Programmable Nanoliter Injector (Drummond Scientific, USA) at a rate of 60 nL/min and retracted from the brain slowly after 5-10 min. For implantation, optic fibers were implanted above the injection site with the DV noted below, and the micro thermistor head was carefully lowered into the hole above the nasal cavity (AP +3.5 from the nasal fissure, ML 0.3). The implants were covered with superglue and dental cement for stabilization. Behavioral experiments were performed three weeks after viral injection and one week after the micro thermistor implantation unless otherwise noted.
For fiber photometry, Oprm1
Cre/+ mice were unilaterally injected with 200 nL of either AAV-DIOjGCaMP7f (1.5 E+14 GC/mL) or control AAV-DIO-eYFP (2.12E+12 GC/mL) into the PBL, and a stainless steel mono-fiber-optic cannula (400 μm diameter, 0.37 NA, Doric Lenses) was implanted 0.05 mm above the injection site.
For chemogenetics, 200 nL of either AAV-DIO-hM3Dq-mCherry (6.56E+11 GC/mL), AAV-DIO-hM4Di-mCherry (6.04E+11 GC/mL, Salk Institute Viral Vector Core), or control AAV-DIO-eYFP (2.12E+12 GC/mL) was injected bilaterally into the PBL of Oprm1 Cre/+ (for hM3Dq) or Oprm1 Cre/Cre (for hM4Di) mice. Cross-correlation analysis between the calcium signals and the respiration data was performed using the zscored data and the MATLAB "xcorr" function using the normalized option, which allows autocorrelations at zero lag to equal 1. The area under the curve (AUC) was calculated with the MATLAB "trapz" function.
In awake behaving animals, concurrent measurements of PBL Oprm1 neural activity and respiration were recorded in the animal's home cage for 20 min with a 55°C hot plate that was custom-built with a TC-720 thermoelectric temperature controller (TE Technology Inc., USA) for four min. In anesthetized animals, concurrent measurements of PBL Oprm1 neural activity and respiration were taken with the delivery of mechanical and thermal pain. For mechanical stimuli, 0 g and 300 g of mechanical pressure were delivered to pinch the tail tip using a dial tension gauge (ATG-300-1, Vetus Instruments, USA). For thermal stimuli, 25°C and 55°C heat were administered to the tail tip using a rod connected to a temperature controller (TA4-SNR+K, Mypin, China). Painful stimuli were delivered for 5 s after a stable 10-s baseline. AUC was calculated for 0-2.5 s before and 2.5-5 s after the mechanical or thermal stimulation, as well as during the 2-min segment before and after the start of the temperature change during the hot-plate assay.
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Convergent cross-mapping
State-space reconstruction models were generated using the framework of convergent cross mapping 3 were determined individually by lagged coordinate embedding using the simplex function implementation in rEDM to optimize predictive skill as measured by the predicted over observed rho. Parameters include the delay tau, which gives the characteristic timescale of the time series, and the embedding dimensionality, which estimates the number of variables driving the system and approximates the real number of variables as given by the Whitney embedding theorem 6 as minimally equal to the real number n of variables, but no more than two times n + 1 ( ≤ ≤ 2 + 1). The choice of tau was also informed by minimizing mutual information 7 . This approximately corresponds to an autocorrelation of ~0.3, which was applied if it maximized predictive skill across datasets. To prevent data contamination, an exclusion radius was applied that was larger than the respiration rate smoothing window of five timesteps. Whenever the data allowed, an exclusion radius of E*tau was applied, unless the data was insufficient to apply this upper bound. In this case, the exclusion radius would be made just larger than tau. In this application CCM was used to generate multidimensional models from embeddings of jGCaMP7s activity that were able to predict respiratory rate using only jGCaMP7s activity.
Chemogenetics
For behavioral testing, clozapine-N-oxide (CNO, Cayman Chemical, USA) was diluted in 0.9% saline to make a 1 mg/mL working solution. A final concentration of 5 mg/kg (for breathing-related tests) or 7.5 mg/kg (for all other behaviors without breathing) was injected intraperitoneally. Behavioral testing began 45-60 min after CNO injection. Animals that did not exhibit expression on one side were excluded from the analysis.
For medullary activation of PBL Oprm1 projections, clozapine (CLZ), a high-affinity agonist for Designer
Receptors Exclusively Activated by Designer Drugs (DREADDs) 8 , was used to activate the PBL Oprm1 axon terminals in the ventrolateral medulla (VLM) respiratory center. Proper controls were included to ensure that CLZ selectively actives DREADD-expressing neurons. CLZ was first solubilized at pH 2.0 with HCl and then diluted. HPBCD [(2-Hydroxypropyl)-β-cyclodextrin] was added to solubilize clozapine with an HBPCD:CLZ molar ratio of 4:1. Solutions were titrated to neutral pH using NaOH and filter sterilized (0.22 5 μm) prior to intracranial administration 9 . CLZ (1 µg/µL) was injected bilaterally to the VLM with 100 nL/side using a glass pipette. A 50-nL aliquot of Cholera Toxin Subunit B-488 was injected using the same coordinates to mark the injection site. Data from 0 -3 min before and 7 -10 min after CLZ injection were used for quantification.
Preparation of acute brain slices and electrophysiology
Mice were anesthetized with isoflurane, and the vascular system was perfused with ice-cold cutting solution (110.0 mM choline chloride, 25.0 mM NaHCO3, 1.25 mM NaH2PO4, 2.5 mM KCl, 0.5 mM CaCl2, 7.0 mM MgCl2, 25.0 mM glucose, 5.0 mM ascorbic acid and 3.0 mM pyruvic acid, bubbled with 95% O2 and 5% CO2). Mice were decapitated, and brains were quickly removed and chilled in ice-cold cutting solution.
Coronal slices containing the PBL (250 μm) were cut using a VT 1200S Vibratome (Leica, Germany) and transferred to a storage chamber containing artificial cerebrospinal fluid (aCSF; 124 mM NaCl, 2.5 mM KCl, 26.2 mM NaHCO3, 1.2 mM NaH2PO4, 13 mM glucose, 2 mM MgSO4 and 2 mM CaCl2, at 32 °C, pH 7.4, bubbled with 95% O2 and 5% CO2). After recovery of at least 30 min, slices were transferred to room temperature (22 -24 °C) for at least 60 min before use.
Slices were transferred into the recording chamber, perfused with aCSF at a flow rate of 2 mL/min. The 
Monosynaptic rabies tracing
Brain slice collection and region assignments were performed according to the Allen Brain Atlas. Every 50 μm section from AP + 2.62 mm to AP -7.455 mm was collected and imaged by an Olympus VS-120 Virtual Slide Scanning Microscope using the OlyVIA software using identical magnification and exposure time.
Neurons with mCherry-positive cell bodies were counted manually. Brain slices located ±0.4 mm anterior and posterior to the starter region were excluded. The injection was unilateral (right side) and the quantification of cells was bilateral. The percentage of the total presynaptic input from a given brain region was calculated by dividing the number of presynaptic neurons by all neurons registered to the atlas.
Elevated-plus maze
To measure anxiety, a custom-built plus-shaped maze with two 77-cm long opposite closed arms, two 77-cm long opposite open arms, and a central square of 7-cm sides was situated 70 cm above the ground.
EthoVision XT 12 software and a GigE USB camera with 25 FPS were used to track the animal. 8
Hot plate test
To measure thermal sensitivity, mice were placed inside a cylindrical, transparent Plexiglass chamber (D = 11 cm, H = 15 cm) on a hot plate (48°C or 55°C, PE34, IITC Life Science, USA). The latency of the painful response (hind paw shake, lick or jump) was manually recorded.
Electronic von Frey test
To measure mechanical sensitivity, the Dynamic Plantar Aesthesiometer (37450, Ugo Basile, Italy) was used with the maximum force set to reach 50 g after 20 s. Mice were habituated inside a Plexiglass chamber (10 x 10 x 13 cm) on a metal mesh floor for >2 h until they were awake but largely immobile. The metal rod was placed underneath the left hind paw of the mice. The system automatically measures the latency and force delivered upon mice hind paw withdrawal. This measurement was taken 5 times with >1 min interval. The averaged value was used for further analysis.
Formalin test
To measure affective pain responses, 4% formalin (1.6% PFA) was injected subcutaneously in the left hind paw of an awake mouse. This produced a biphasic pain response over a 1-h test period. Mice were placed 
Contextual fear conditioning
The fear-conditioning chamber (ENV-007CT, MED Associates INC, USA) is an arena (26 x 30 x 33 cm) with two Plexiglass walls, two metal walls, and a metal grid floor to deliver electrical shocks (ENV-005, MED Associates INC). The chamber was connected to a standalone aversive stimulator (ENV-414S, MED
Associates INC) and enclosed in a light-and sound-attenuating cubicle (ENV-018MD, MED Associates INC). EthoVision XT 12 software and a GigE USB camera with 25 FPS were used to track the animal. A 70% ethanol solution and deionized water were used for cleaning immediately after each test. On day 1 and day 2, mice underwent two 6-min habituation sessions in the chamber. On day 3, mice were introduced to the chamber 45-60 min after CNO injection and subsequently received five shocks (2 s, 0.2 mA) with uneven intervals during a 7-min trial. After 24 h, mice were reintroduced to the chamber for a 2-min contextdependent retrieval test. The percentage of time freezing and the total distance moved during each session were calculated by the EthoVision XT 12 software. Freezing behavior was defined as the period during which the velocity of the mouse was less than 1.75 cm/s for at least 3 s. Automatic scoring was validated with manual scoring.
Statistical analysis
All data are shown as mean ± SEM and analyzed using either a student's t-test, one-way ANOVA with Tukey's post hoc comparison, or two-way ANOVA with Bonferroni's post hoc comparison. All the statistical analyses were performed with Prism 6 (GraphPad Software Inc., USA). ns, not significant; *, p < 0.05; **, p < 0.01; ***, p < 0.001; ****, p < 0.0001.
Data availability
The data that support the findings of this study are available from the corresponding author upon reasonable request. ns, not significant; ****, p < 0.0001.
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